Literature DB >> 3568455

The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

P Fitzharris, R Moqbel, K J Thorne, B A Richardson, A Hartnell, O Cromwell, A E Butterworth, A B Kay.   

Abstract

Eosinophil activating factor (EAF) is a 40 kD protein released from cultured, unstimulated human monocytes which enhances the IgG-dependent eosinophil-mediated cytotoxicity of helminthic larvae. We have recently shown that eosinophils elaborate substantial quantities of leukotriene C4 (LTC4) during incubation with IgG-coated particles and now report that EAF, partially purified by sequential chromatography on Sephacryl S-200 and DEAE-cellulose, enhanced this IgG-dependent LTC4 production by human eosinophils in a dose- and time-dependent fashion. LTC4 production by normal density eosinophils, separated on discontinuous metrizamide gradients, was significantly increased after incubation with several dilutions of EAF (P less than 0.05), although an increase was not seen with low density cells. The enhancement was similar in degree to that seen when normal density eosinophils were activated with the bacterial analogue, f-met-leu-phe (fMLP). EAF produced a time-dependent increase in LTC4 which was significantly greater (P less than 0.01) than the control. Sulphidopeptide leukotriene (LT) generation was validated by reverse phase high pressure liquid chromatography (RP-HPLC). These results indicate that there is a firm association between monocytes, eosinophils and LTC4; an observation which may be of relevance to mechanisms in chronic asthma and related disorders, and in immune reactions against migrating helminthic larvae.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3568455      PMCID: PMC1542475     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Partial purification and biological properties of an eosinophil-activating factor.

Authors:  K J Thorne; B A Richardson; M C Veith; P C Tai; C J Spry; A E Butterworth
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

2.  Activation of human eosinophils by monokines and lymphokines: source and biochemical characteristics of the eosinophil cytotoxicity-enhancing activity produced by blood mononuclear cells.

Authors:  H L Lenzi; A D Mednis; A J Dessein
Journal:  Cell Immunol       Date:  1985-09       Impact factor: 4.868

Review 3.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

4.  Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions.

Authors:  S R Durham; A B Kay
Journal:  Clin Allergy       Date:  1985-09

5.  Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation.

Authors:  R J Shaw; G M Walsh; O Cromwell; R Moqbel; C J Spry; A B Kay
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

Review 6.  Cell-mediated damage to helminths.

Authors:  A E Butterworth
Journal:  Adv Parasitol       Date:  1984       Impact factor: 3.870

7.  Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187.

Authors:  A J Dessein; T H Lee; P Elsas; J Ravalese; D Silberstein; J R David; K F Austen; R A Lewis
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

8.  Enteral and systemic release of leukotrienes during anaphylaxis of Nippostrongylus brasiliensis-primed rats.

Authors:  R Moqbel; S J King; A J MacDonald; H R Miller; O Cromwell; R J Shaw; A B Kay
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

9.  Plasma membrane antigens on light density and activated human blood eosinophils.

Authors:  P C Tai; D M Bakes; J R Barkans; C J Spry
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

10.  Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U60257 and BW755C.

Authors:  O Cromwell; R J Shaw; G M Walsh; A I Mallet; A B Kay
Journal:  Int J Immunopharmacol       Date:  1985
View more
  3 in total

1.  Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.

Authors:  T Yukawa; C Kroegel; P Evans; T Fukuda; K F Chung; P J Barnes
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

2.  Release of O2- and LTC4 by murine eosinophils: role of intra- and extracellular calcium.

Authors:  B de Andres; V del Pozo; E Martin; P Palomino; C Lahoz
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

3.  Leukotriene B4 generation by human neutrophils following IgG-dependent stimulation.

Authors:  P Fitzharris; O Cromwell; R Moqbel; A Hartnell; G M Walsh; C Harvey; A B Kay
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.